http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109081856-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F17-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2018-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109081856-B
titleOfInvention 4-ferrocenyl-6-aryl-2-aminopyrimidine compound and preparation method thereof
abstract The invention discloses a preparation method for preparing 4-ferrocenyl-6-aryl-2-aminopyrimidine, which comprises the following steps: adding the formula amount of ferrocenyl chalcone (A) into a reaction vessel, and fully stirring and dissolving methanol which is used as a solvent at room temperature; then adding guanidine hydrochloride (B) and alkali (C) with formula amount, slowly heating to reflux temperature, and monitoring by TLC until the reaction is finished; adding a proper amount of water into the reaction system, stirring uniformly, standing, separating liquid, drying an organic phase by using anhydrous magnesium sulfate, filtering, and performing rotary evaporation to obtain a crude product; the crude product is purified by column chromatography, and the yield can reach more than 70 percent; wherein A, B and C are 1: (4-6): (4-9). The invention also researches the antitumor activity of the compound, and experiments show that the compound has certain inhibitory activity on PC-3 cells of prostate cancer, and the obtained product has certain application prospect in the field of anticancer.
priorityDate 2018-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7611
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451774801
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157906097
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID23591
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454589912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6452212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452365300
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7189
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448578961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20257314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457798390
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448277656
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158789849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450395493
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449773822
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160636750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426146645
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546720

Total number of triples: 41.